ctrl K

Applied Therapeutics Inc. (APLT)

NASDAQ: APLT · Real-Time Price · USD

0.41

0.00 (0.20%)

At close: May 01, 2025, 3:59 PM

0.42

3.02%

Pre-market: May 02, 2025, 09:20 AM EDT

Applied Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	455K	9.99M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	425K	353K	441K	415K	380K	23K	n/a	n/a
Gross Profit	30K	9.64M	-441K	-415K	-380K	-23K	n/a	n/a
Operating Income	-104.3M	-64.53M	-82.95M	-105.62M	-94.47M	-45.58M	-13.52M	-4.29M
Interest Income	3.53M	1.37M	685K	555K	559K	93K	n/a	n/a
Pretax Income	-105.62M	-119.76M	-82.51M	-105.58M	-93.96M	-45.51M	-16.52M	-4.28M
Net Income	-105.62M	-119.76M	-81.69M	-104.61M	-93.02M	-45.4M	-16.52M	-4.28M
Selling & General & Admin	56.01M	20.62M	27.32M	43.05M	32.68M	13.23M	2.05M	582K
Research & Development	48.74M	53.91M	55.63M	62.57M	61.79M	32.35M	11.47M	3.7M
Other Expenses	n/a	n/a	-177K	-521K	-54K	-24K	-1.14M	n/a
Operating Expenses	104.75M	74.53M	82.95M	105.62M	94.47M	45.58M	13.52M	4.29M
Interest Expense	n/a	n/a	n/a	555K	559K	93K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	104.75M	74.53M	82.95M	105.62M	94.47M	45.58M	13.52M	4.29M
Income Tax Expense	n/a	n/a	-819K	-970K	-939K	-116K	4.87M	-4.29M
Shares Outstanding (Basic)	139.53M	84.24M	37.83M	25.6M	21.97M	12.83M	9.16M	9.16M
Shares Outstanding (Diluted)	139.53M	84.24M	37.83M	25.6M	21.97M	12.83M	9.16M	9.16M
EPS (Basic)	-0.76	-1.42	-2.16	-4.09	-4.23	-3.54	-1.8	-0.47
EPS (Diluted)	-0.76	-1.42	-2.16	-4.09	-4.23	-3.54	-1.8	-0.47
EBITDA	-103.87M	-64.53M	-82.07M	-105.17M	-94.47M	-45.58M	-3M	3K
EBIT	-104.3M	-64.53M	-82.51M	-105.58M	-93.96M	-45.51M	-14.88M	-4.28M
Depreciation & Amortization	425K	1K	441K	415K	380K	23K	13.52M	4.29M